chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Platelet count normal, Productive cough, Red blood cell count decreased, Red cell distribution width normal
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10028735:NASAL CONGESTION; 10052521:NASAL SINUS DRAINAGE; Narrative: Pt initially seen in ED on 5/8/23 with c/o sinus drainage, nasal congestion, and cough with yellow mucous. Pt states she was wheezing at night. COVID test was negative. Pt sent home with prednisone, Augmentin, Mucinex, and Tessalon Perles. Pt also reports being seen 5/11/23 at urgent care where she received shot of dexamethasone, which helped temporarily until symptoms returned. 5/17/23 - Pt returned to ED with c/o productive cough (to the point of gagging) and wheezing x 2 weeks. Pt states no improvement seen with meds discharged on from 5/8. In ED, Pt given hour long Duoneb treatment but still unable to cough up congestion. Following Duoneb and Decadron IV, Pt was moving air slightly better but still having some difficulty and has expiratory wheezes in all lung fields. Arrangements made for patient admission on 5/17/23. Per 5/22/23 discharge summary: PRINCIPAL DIAGNOSIS): Acute Asthma Excerabation d/t Positive COVID 19 Infection Acute COVID 19 Infection Elevated D Dimer, Pulmonary Embolis & DVT Ruled Out Acute on Chronic Kidney Disease Stage IIIb/IV ADDITIONAL DIAGNOSES: Chronic kidney Disease Stage IIIb/IV CAD s/p NSTEMI 2010 Chronic Diastolic CHF Hypertension Hypothyroidism s/p Thyroidectomy Obesity - BMI 33 Chronic Insomnia Hospital course: supportive care and monitoring was initiated to include but not limited to remedesivir was initiated, ICS (mometasone), PRN supplemental oxygen, home medication atenolol was held/and tiotropium inhaler
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sinus operation, Sputum discoloured, Wheezing, White blood cell count normal
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10028735:NASAL CONGESTION; 10052521:NASAL SINUS DRAINAGE; Narrative: Pt initially seen in ED on 5/8/23 with c/o sinus drainage, nasal congestion, and cough with yellow mucous. Pt states she was wheezing at night. COVID test was negative. Pt sent home with prednisone, Augmentin, Mucinex, and Tessalon Perles. Pt also reports being seen 5/11/23 at urgent care where she received shot of dexamethasone, which helped temporarily until symptoms returned. 5/17/23 - Pt returned to ED with c/o productive cough (to the point of gagging) and wheezing x 2 weeks. Pt states no improvement seen with meds discharged on from 5/8. In ED, Pt given hour long Duoneb treatment but still unable to cough up congestion. Following Duoneb and Decadron IV, Pt was moving air slightly better but still having some difficulty and has expiratory wheezes in all lung fields. Arrangements made for patient admission on 5/17/23. Per 5/22/23 discharge summary: PRINCIPAL DIAGNOSIS): Acute Asthma Excerabation d/t Positive COVID 19 Infection Acute COVID 19 Infection Elevated D Dimer, Pulmonary Embolis & DVT Ruled Out Acute on Chronic Kidney Disease Stage IIIb/IV ADDITIONAL DIAGNOSES: Chronic kidney Disease Stage IIIb/IV CAD s/p NSTEMI 2010 Chronic Diastolic CHF Hypertension Hypothyroidism s/p Thyroidectomy Obesity - BMI 33 Chronic Insomnia Hospital course: supportive care and monitoring was initiated to include but not limited to remedesivir was initiated, ICS (mometasone), PRN supplemental oxygen, home medication atenolol was held/and tiotropium inhaler
Sex: M
Vaccine: FLUX
Symptoms: Headache, Hypertension
Clinical narrative: Reported Symptoms: 10019211:HEADACHE; 10020772:HYPERTENSION; Narrative: Other Relevant HX: Patient presented to PCP for follow up on 4/24/23. During this visit, Patient was screened and offered influenza vaccine. Per 4/24/23 Medicine Clinic Nursing Note, Patient refused to receive influenza vaccine due to "severe reaction to previous dose of severe high blood pressure and head ache- seen in the ER." Per chart review, appears Patient is reporting a previous reaction to influenza vaccine. Per chart review, influenza vaccine was not ordered or received on 4/24/23. This is consistent with documentation of event has "historical" in the chart. Other: HYPERTENSION; HEADACHE
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, SARS-CoV-2 test positive, Syncope, Vaccine breakthrough infection
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084355:COVID-19 VIRUS TEST POSITIVE; Narrative: Hospitalization: fully vaccinated COVID 19 positive (Admitted for weakness and syncope) Other Relevant HX: Other: Hospitalization: fully vaccinated COVID 19 positive
Sex: M
Vaccine: FLUX
Symptoms: Anaphylactic reaction
Clinical narrative: Reported Symptoms:  10003318:ANAPHYLAXIS; Narrative: A 50yo male presented to the OC - PCC on April 4, 2023, to establish are and was reported by a health technician, with a historical ADR of Influenza vaccine induced anaphylaxis, which was added to the patient's allergy profile. No other information was provided regarding product, where, when and by who the vaccine was administered or treatment received.  Other Relevant HX; Other: ANAPHYLAXIS
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19, SARS-CoV-2 test positive, Syncope, Vaccine breakthrough infection
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084355:COVID-19 VIRUS TEST POSITIVE; 10084459:ASYMPTOMATIC COVID-19; Narrative: Hospitalization- COIVD positive fully vaccinated, asymptomatic (Admitted for syncope) Other Relevant HX: Other: Hospitalization- COIVD positive fully vaccinated, asymptomatic
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Dyspnoea, Lethargy
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: Patient presented to ED with complaint of shortness of breath and lethargy. Admitted for acute on chronic hypoxemic/hypercarbic respiratory failure  secondary to COVID pneumonia. Continued home nebulizers, methylprednisolone 20mg IV twice daily. On day 2 of admission, methylprednisolone changed to dexamethasone and remdesivir initiated. Continues to be hospitalized. Other Relevant HX: Other: COVID HOSPITALIZATION
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory failure
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: Patient presented to ED with complaint of shortness of breath and lethargy. Admitted for acute on chronic hypoxemic/hypercarbic respiratory failure  secondary to COVID pneumonia. Continued home nebulizers, methylprednisolone 20mg IV twice daily. On day 2 of admission, methylprednisolone changed to dexamethasone and remdesivir initiated. Continues to be hospitalized. Other Relevant HX: Other: COVID HOSPITALIZATION
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Dizziness, Sinus bradycardia
Clinical narrative: Reported Symptoms: 10013573:DIZZINESS; Narrative: 5/30/2023 - pt received 1st dose of shingrix vaccine during PCP appt. pt reported symptomatic dizziness after injection and had sinus bradycardia. pt was advised to go to the nearest ER for follow up testing. pt was seen in ER, was not admitted and discharged with no medication treatment or further action required. Other Relevant HX: Other: DIZZINESS
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19-2, COVID19-2
Symptoms: COVID-19
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; Narrative: Patient hospitalized for COVID-19 infection. Patient received supportive care and remained on room air. Was discharged after two days of hospital stay. Other Relevant HX: Other: Hospitalization
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Deep vein thrombosis, Haematology test, Ligament sprain, Osteoarthritis
Clinical narrative: Reported Symptoms: 10043607:THROMBOSIS; Narrative: 2nd COVID-19 (MODERNA) vaccine documented on 08/21/2021 in record. 1st dose 7/24/2021 3/28/2022: Patient reported to orthopedic provider for bilateral knee pain and complained of increasing pain in the left lower leg. Patient reported that he twisted left knee over weekend and had X-rays taken. X-rays show OA of knee, otherwise unremarkable. Patient sent for STAT doppler and was diagnosed with DVT. Apixaban started and patient was instructed to follow-up with PCM for chronic management. PAST SURGICAL HISTORY: Left ankle surgery on two occasions in 2000 and again in 2014. On 4/11/2023 facility PCP documented that patient had left DVT status post COVID-vaccine in 2022. Reviewed non facility provider notes from 5/5/2023. Provider wrote that he agreed w hematology eval and patient should stay on apixaban due to looks like spontaneous DVT/PE so he will need on apixaban for long time. Hematology evaluation not available in record. Other Relevant HX: Other: THROMBOSIS
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Thrombosis, Ultrasound Doppler abnormal, X-ray limb abnormal
Clinical narrative: Reported Symptoms: 10043607:THROMBOSIS; Narrative: 2nd COVID-19 (MODERNA) vaccine documented on 08/21/2021 in record. 1st dose 7/24/2021 3/28/2022: Patient reported to orthopedic provider for bilateral knee pain and complained of increasing pain in the left lower leg. Patient reported that he twisted left knee over weekend and had X-rays taken. X-rays show OA of knee, otherwise unremarkable. Patient sent for STAT doppler and was diagnosed with DVT. Apixaban started and patient was instructed to follow-up with PCM for chronic management. PAST SURGICAL HISTORY: Left ankle surgery on two occasions in 2000 and again in 2014. On 4/11/2023 facility PCP documented that patient had left DVT status post COVID-vaccine in 2022. Reviewed non facility provider notes from 5/5/2023. Provider wrote that he agreed w hematology eval and patient should stay on apixaban due to looks like spontaneous DVT/PE so he will need on apixaban for long time. Hematology evaluation not available in record. Other Relevant HX: Other: THROMBOSIS
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19, Headache, Respiratory symptom, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Reported Symptoms: 10019211:HEADACHE; 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10078455:UPPER RESPIRATORY SYMPTOM; 10084355:COVID-19 VIRUS TEST POSITIVE; Narrative: Hospitalization- COVID positive fully vaccinated, (Admitted with headache and URI symptoms- received 2 doses of remdesivir and discharged)) Other Relevant HX: Other: Hospitalization- COVID positive fully vaccinated, Headache and URI symptoms
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anion gap normal, Blood culture positive, Blood glucose increased, Breath sounds abnormal
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10041367:SORE THROAT; Narrative: 3/9/23 - Pt presented to ED after being told at Clinic that his blood glucose was >500 (stated he had been w/o insulin for 1-1/2 months), states he has had a cough and every time he swallows his throat aches. Respirations even, non-labored. Breath sounds diminished to left base and scattered rales right base. ED Course: Given a liter lactated Ringer IV and 10 units of insulin IV (glucose - 737). Admission was requested for hyperosmolar nonketotic hyperglycemia. Discussed admission with the intensive care unit. However they felt that because he was hemodynamically stable had a normal CO2 and anion gap he could be treated on the floor. He does not have ketones in his urine. He does not appear to be in DKA. He had no respiratory issues from COVID-19. Admission DIAGNOSIS: (1) Primary Diagnosis: Hyperosmolar hyperglycemia without coma (2) COVID-19 positive PLAN: Admit to medicine 3/9/23. Pt stay was from 3/9 to 3/16. Pt evaluated on medicine floor. PRINCIPAL DIAGNOSIS (Reason for admission after study): 1. Hyperosmolar nonketotic hyperglycemia 2. Community-acquired pneumonia 3. Klebsiella pneumoniae bacteremia 4. Sepsis 5. COVID-19 infection 6. Acute hypoxic respiratory failure Hospital Course - COVID related: COVID-19 infection -Vaccinated x 3 -Diagnosed on 03/09/2023 -S/P Remdesivir and Decadron -Continue respiratory/droplet isolation and supportive care Community-acquired pneumonia -Blood culture from 03/09/2023 grew Klebsiella pneumoniae
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Carbon dioxide normal, Cough, Hyperglycaemic hyperosmolar nonketotic syndrome, Insulin therapy
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10041367:SORE THROAT; Narrative: 3/9/23 - Pt presented to ED after being told at Clinic that his blood glucose was >500 (stated he had been w/o insulin for 1-1/2 months), states he has had a cough and every time he swallows his throat aches. Respirations even, non-labored. Breath sounds diminished to left base and scattered rales right base. ED Course: Given a liter lactated Ringer IV and 10 units of insulin IV (glucose - 737). Admission was requested for hyperosmolar nonketotic hyperglycemia. Discussed admission with the intensive care unit. However they felt that because he was hemodynamically stable had a normal CO2 and anion gap he could be treated on the floor. He does not have ketones in his urine. He does not appear to be in DKA. He had no respiratory issues from COVID-19. Admission DIAGNOSIS: (1) Primary Diagnosis: Hyperosmolar hyperglycemia without coma (2) COVID-19 positive PLAN: Admit to medicine 3/9/23. Pt stay was from 3/9 to 3/16. Pt evaluated on medicine floor. PRINCIPAL DIAGNOSIS (Reason for admission after study): 1. Hyperosmolar nonketotic hyperglycemia 2. Community-acquired pneumonia 3. Klebsiella pneumoniae bacteremia 4. Sepsis 5. COVID-19 infection 6. Acute hypoxic respiratory failure Hospital Course - COVID related: COVID-19 infection -Vaccinated x 3 -Diagnosed on 03/09/2023 -S/P Remdesivir and Decadron -Continue respiratory/droplet isolation and supportive care Community-acquired pneumonia -Blood culture from 03/09/2023 grew Klebsiella pneumoniae
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Klebsiella bacteraemia, Klebsiella test positive, Odynophagia, Oropharyngeal pain, Pneumonia
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10041367:SORE THROAT; Narrative: 3/9/23 - Pt presented to ED after being told at Clinic that his blood glucose was >500 (stated he had been w/o insulin for 1-1/2 months), states he has had a cough and every time he swallows his throat aches. Respirations even, non-labored. Breath sounds diminished to left base and scattered rales right base. ED Course: Given a liter lactated Ringer IV and 10 units of insulin IV (glucose - 737). Admission was requested for hyperosmolar nonketotic hyperglycemia. Discussed admission with the intensive care unit. However they felt that because he was hemodynamically stable had a normal CO2 and anion gap he could be treated on the floor. He does not have ketones in his urine. He does not appear to be in DKA. He had no respiratory issues from COVID-19. Admission DIAGNOSIS: (1) Primary Diagnosis: Hyperosmolar hyperglycemia without coma (2) COVID-19 positive PLAN: Admit to medicine 3/9/23. Pt stay was from 3/9 to 3/16. Pt evaluated on medicine floor. PRINCIPAL DIAGNOSIS (Reason for admission after study): 1. Hyperosmolar nonketotic hyperglycemia 2. Community-acquired pneumonia 3. Klebsiella pneumoniae bacteremia 4. Sepsis 5. COVID-19 infection 6. Acute hypoxic respiratory failure Hospital Course - COVID related: COVID-19 infection -Vaccinated x 3 -Diagnosed on 03/09/2023 -S/P Remdesivir and Decadron -Continue respiratory/droplet isolation and supportive care Community-acquired pneumonia -Blood culture from 03/09/2023 grew Klebsiella pneumoniae
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia klebsiella, Product use issue, Rales, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10041367:SORE THROAT; Narrative: 3/9/23 - Pt presented to ED after being told at Clinic that his blood glucose was >500 (stated he had been w/o insulin for 1-1/2 months), states he has had a cough and every time he swallows his throat aches. Respirations even, non-labored. Breath sounds diminished to left base and scattered rales right base. ED Course: Given a liter lactated Ringer IV and 10 units of insulin IV (glucose - 737). Admission was requested for hyperosmolar nonketotic hyperglycemia. Discussed admission with the intensive care unit. However they felt that because he was hemodynamically stable had a normal CO2 and anion gap he could be treated on the floor. He does not have ketones in his urine. He does not appear to be in DKA. He had no respiratory issues from COVID-19. Admission DIAGNOSIS: (1) Primary Diagnosis: Hyperosmolar hyperglycemia without coma (2) COVID-19 positive PLAN: Admit to medicine 3/9/23. Pt stay was from 3/9 to 3/16. Pt evaluated on medicine floor. PRINCIPAL DIAGNOSIS (Reason for admission after study): 1. Hyperosmolar nonketotic hyperglycemia 2. Community-acquired pneumonia 3. Klebsiella pneumoniae bacteremia 4. Sepsis 5. COVID-19 infection 6. Acute hypoxic respiratory failure Hospital Course - COVID related: COVID-19 infection -Vaccinated x 3 -Diagnosed on 03/09/2023 -S/P Remdesivir and Decadron -Continue respiratory/droplet isolation and supportive care Community-acquired pneumonia -Blood culture from 03/09/2023 grew Klebsiella pneumoniae
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Urine ketone body absent
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10041367:SORE THROAT; Narrative: 3/9/23 - Pt presented to ED after being told at Clinic that his blood glucose was >500 (stated he had been w/o insulin for 1-1/2 months), states he has had a cough and every time he swallows his throat aches. Respirations even, non-labored. Breath sounds diminished to left base and scattered rales right base. ED Course: Given a liter lactated Ringer IV and 10 units of insulin IV (glucose - 737). Admission was requested for hyperosmolar nonketotic hyperglycemia. Discussed admission with the intensive care unit. However they felt that because he was hemodynamically stable had a normal CO2 and anion gap he could be treated on the floor. He does not have ketones in his urine. He does not appear to be in DKA. He had no respiratory issues from COVID-19. Admission DIAGNOSIS: (1) Primary Diagnosis: Hyperosmolar hyperglycemia without coma (2) COVID-19 positive PLAN: Admit to medicine 3/9/23. Pt stay was from 3/9 to 3/16. Pt evaluated on medicine floor. PRINCIPAL DIAGNOSIS (Reason for admission after study): 1. Hyperosmolar nonketotic hyperglycemia 2. Community-acquired pneumonia 3. Klebsiella pneumoniae bacteremia 4. Sepsis 5. COVID-19 infection 6. Acute hypoxic respiratory failure Hospital Course - COVID related: COVID-19 infection -Vaccinated x 3 -Diagnosed on 03/09/2023 -S/P Remdesivir and Decadron -Continue respiratory/droplet isolation and supportive care Community-acquired pneumonia -Blood culture from 03/09/2023 grew Klebsiella pneumoniae
Age: 47.0
Sex: M
Vaccine: COVID19-2
Symptoms: Dyspnoea, Facial discomfort, Muscle tightness, Musculoskeletal stiffness, Throat tightness
Clinical narrative: Reported Symptoms: 10012791:DIFFICULTY BREATHING; 10028842:NECK STIFF; 10040604:SHORTNESS OF BREATH; 10049816:MUSCLE TIGHTNESS; Narrative: Inpatient received a covid 19 (Moderna) 2nd booster injection. Within 5 minutes he approached the desk and said his throat felt tight and the right side of his face feels tight. Pt was placed on a 1:1 for observation. Vitals were checked. Pt was given 2 doses of diphenhydramine 25mg oral at ~5pm and 10pm. Pt was continued to be monitored. Pt's chart was flagged with ADR to it and this VAERS submitted. Other Relevant HX: Other: throat and face feel tight; shortness of breath and difficulty breathing
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 63yoM presented with chief complaint of SOB. Denies chest pain and SOB. Relevant PMH includes asthma and COPD from coal mines. Using CPAP at night for sleep apnea. Respiration rate in ED was 28. Given dexamethasone 125mg IV once in ED. Admitted and given dexamethasone 6mg daily, ceftriaxone 1g daily, and azithromycin 500mg daily. Currently on Day 2 of hospitalization. Other Relevant HX: Other: COVID HOSPITALIZATION
Age: 51.0
Sex: M
Vaccine: FLUX
Symptoms: Myalgia, Pyrexia
Clinical narrative: Reported Symptoms: 10016558:FEVER; 10028322:MUSCLE PAIN; Narrative: Pt reported history of reaction from influenza vaccine. Pt got fever and muscle pain in the past attributed to flu shot. Md flagged pt's chart with ADR to it. Other Relevant HX: Other: fever & muscle pain
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19 pneumonia, Chills, Cough, Headache, Hepatitis
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10016598:FEVER; 10019211:HEADACHE; 10047700:VOMITING; 10084380:COVID-19 PNEUMONIA; Narrative: Patient received three doses of Moderna COVID 19 Vaccine (Feb/Mar/Dec 2021). The patient presented to the Emergency Department on 4 Jan 2023 with chills, fever, cough, headache, and nausea that he had for approximately one week. The patient tested positive for COVID 19 on 4 Jan 2023 and was admitted to the hospital with COVID pneumonia and abnormal LFTs (mild hepatitis). The patient was treated with remdesivir, dexamethasone, and inhalation therapy. The patient was discharged on 7 Jan 2023 in stable condition. Reported per EUA. Other Relevant HX: Other: covid 19 pneumonia
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Liver function test abnormal, Nausea, Pyrexia, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10016598:FEVER; 10019211:HEADACHE; 10047700:VOMITING; 10084380:COVID-19 PNEUMONIA; Narrative: Patient received three doses of Moderna COVID 19 Vaccine (Feb/Mar/Dec 2021). The patient presented to the Emergency Department on 4 Jan 2023 with chills, fever, cough, headache, and nausea that he had for approximately one week. The patient tested positive for COVID 19 on 4 Jan 2023 and was admitted to the hospital with COVID pneumonia and abnormal LFTs (mild hepatitis). The patient was treated with remdesivir, dexamethasone, and inhalation therapy. The patient was discharged on 7 Jan 2023 in stable condition. Reported per EUA. Other Relevant HX: Other: covid 19 pneumonia
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Angina pectoris, Anosmia, COVID-19, Chest pain, Confusional state
Clinical narrative: Reported Symptoms: 10002391:ANGINAL PAIN; 10010300:CONFUSION; 10011232:COUGHING; 10012727:DIARRHEA; 10016581:FIBRIN D DIMER INCREASED; 10028411:MYALGIA; 10084268:COVID-19; Narrative: Patient received five doses of Pfizer COVID 19 vaccine. The patient presented to the ED on 20 Jan 23 with chest pain, cough, diarrhea, headache, loss of smell, and leg pain. The  patient tested positive on 20 Jan 23 for COVID 19 and was admitted for monitoring. The patient also had elevated D-dimer changes. The patient was treated for symptoms. The patient was discharged in stable condition on 24 Jan 23. Reported per EUA. Other Relevant HX: Other COVID 19, elevated d-dimer
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Cough, Diarrhoea, Fibrin D dimer increased, Headache, Myalgia
Clinical narrative: Reported Symptoms: 10002391:ANGINAL PAIN; 10010300:CONFUSION; 10011232:COUGHING; 10012727:DIARRHEA; 10016581:FIBRIN D DIMER INCREASED; 10028411:MYALGIA; 10084268:COVID-19; Narrative: Patient received five doses of Pfizer COVID 19 vaccine. The patient presented to the ED on 20 Jan 23 with chest pain, cough, diarrhea, headache, loss of smell, and leg pain. The  patient tested positive on 20 Jan 23 for COVID 19 and was admitted for monitoring. The patient also had elevated D-dimer changes. The patient was treated for symptoms. The patient was discharged in stable condition on 24 Jan 23. Reported per EUA. Other Relevant HX: Other COVID 19, elevated d-dimer
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pain in extremity, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10002391:ANGINAL PAIN; 10010300:CONFUSION; 10011232:COUGHING; 10012727:DIARRHEA; 10016581:FIBRIN D DIMER INCREASED; 10028411:MYALGIA; 10084268:COVID-19; Narrative: Patient received five doses of Pfizer COVID 19 vaccine. The patient presented to the ED on 20 Jan 23 with chest pain, cough, diarrhea, headache, loss of smell, and leg pain. The  patient tested positive on 20 Jan 23 for COVID 19 and was admitted for monitoring. The patient also had elevated D-dimer changes. The patient was treated for symptoms. The patient was discharged in stable condition on 24 Jan 23. Reported per EUA. Other Relevant HX: Other COVID 19, elevated d-dimer
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blister, Cellulitis, Lymphoedema, Pain in extremity, Peripheral swelling
Clinical narrative: Reported Symptoms: 10005216:BLISTERS; Narrative: Other Relevant HX: 75 yo male patient with CKD, Type 2 DM, HCL received the COVID-19 PFIZER BIVALENT BOOSTER, PF, 30 MCG/0.3 INTRAMUSCLAR/RIGHT DELTOID on 1/23/23. Pt presented to the ED on 1/26/23 for CC: right lower extremity swelling. He has chronic lymphedema of the bilateral lower extremities. He had been wrapping his own legs with bandages and Coban at home. He noticed that the right leg was progressively more swollen compared to the left since 1/23/23 when he saw primary care provider. He denies any fevers and chills. His legs were painful due to the swelling. He noticed a large blister formation overlying the right lower anterior tibial region over the last day. Pt admitted for wound care and antibiotic therapy. Per attending physician on 1/27/23, bullous drug reaction RLE>LLE, likely secondary to bivalent Pfizer COVID-19 vaccine administered on 1/23/23. R>L BLE cellulitis due to above.. Pt treated with AMPICILLIN/SULBACTOM 3GM/100ML INJ and prednisone 50mg x 4days for bullous drug reaction, wound care consulted for daily wound care. Pt discharged home following 11 day inpatient admission. Other: BLISTER (1/24/23@08:18)
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Angioedema, Hypersensitivity, Lip swelling, Pruritus, Urticaria
Clinical narrative: Reported Symptoms: 10002424:ANGIOEDEMA; 10037087:PRURITUS;    Narrative: presented to ER with complaints of hives, swollen bottom lips, and wheezing. Pt reported symptoms started in the evening and was concerned it was secondary to his zoster vaccine that he received earlier in the day. Pt took 25mg of PO Benadryl at home along with his albuterol inhaler. No reports of chest pain or palpitations. Allergic Reaction improved in the ER with IV methylprednisolone, diphenhydramine, and famotidine. Discharged home with Medrol dose pack and diphenhydramine.  Allergy documented in patient's record.  Other Relevant HX:  Other: PRURITUS (2/8/23@3:23:28); ANGIOEDEMA (2/8/23@02:23:28)
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Wheezing
Clinical narrative: Reported Symptoms: 10002424:ANGIOEDEMA; 10037087:PRURITUS;    Narrative: presented to ER with complaints of hives, swollen bottom lips, and wheezing. Pt reported symptoms started in the evening and was concerned it was secondary to his zoster vaccine that he received earlier in the day. Pt took 25mg of PO Benadryl at home along with his albuterol inhaler. No reports of chest pain or palpitations. Allergic Reaction improved in the ER with IV methylprednisolone, diphenhydramine, and famotidine. Discharged home with Medrol dose pack and diphenhydramine.  Allergy documented in patient's record.  Other Relevant HX:  Other: PRURITUS (2/8/23@3:23:28); ANGIOEDEMA (2/8/23@02:23:28)
Sex: M
Vaccine: PNC20
Symptoms: Hypotension, Injection site pain, Injection site swelling, Myalgia
Clinical narrative: Reported Symptoms: 10021097:HYPOTENSION; 10022086:INJECTION SITE PAIN; 10058411:MYALGIA; 10053425:INJECTION SITE SWELLING; Narrative: Other Relevant HX: Other: INJECTION SITE SWELLING, INJECTION SITE PAIN
Age: 48.0
Sex: F
Vaccine: COVID19-2
Symptoms: Diarrhoea, Injection site reaction, Lymph node pain, Lymphadenopathy
Clinical narrative: Reported Symptoms: 10012727:DIARRHEA; 10018299:GLANDS SWOLLEN; Narrative: COVID-19 VACCINE booster was administered on 12/13/22 at the hospital. On 12/16/22 patient called to report symptoms of diarrhea, and a sore, swollen gland left side near injection site. Patient was advised "to call the RN triage line for any new or worsening symptoms or if symptoms are not improved by 12/19/22." There is no further record of patient communicating further issues or updates to the hospital. Other Relevant HX: Other: swollen gland
Age: 66.0
Sex: M
Vaccine: PPV
Symptoms: Asthenia, Cough, Fatigue, Gait disturbance, Headache
Clinical narrative: Reported Symptoms: 10016558:FEVER; Narrative: The patient is a 66-year-old male presenting for generalized weakness and fatigue. Onset of symptoms yesterday. Last night he noted he began feeling some fatigue. Symptoms progressively worsened throughout the day today. He felt unstable walking and doing activities due to degree of generalized weakness and fatigue. He has associated headache, sinus congestion, sinus drainage, and intermittent cough. Denies vision change, vision loss, photophobia, neck stiffness, nausea/vomiting, chest pain, shortness of breath, abdominal pain, dysuria, urinary frequency, or diarrhea. Reports having pneumonia vaccine 3 days ago Other Relevant HX: Other: FEVER
Age: 66.0
Sex: M
Vaccine: PPV
Symptoms: Loss of personal independence in daily activities, Paranasal sinus hypersecretion, Pyrexia, Sinus congestion
Clinical narrative: Reported Symptoms: 10016558:FEVER; Narrative: The patient is a 66-year-old male presenting for generalized weakness and fatigue. Onset of symptoms yesterday. Last night he noted he began feeling some fatigue. Symptoms progressively worsened throughout the day today. He felt unstable walking and doing activities due to degree of generalized weakness and fatigue. He has associated headache, sinus congestion, sinus drainage, and intermittent cough. Denies vision change, vision loss, photophobia, neck stiffness, nausea/vomiting, chest pain, shortness of breath, abdominal pain, dysuria, urinary frequency, or diarrhea. Reports having pneumonia vaccine 3 days ago Other Relevant HX: Other: FEVER
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: COVID-19 pneumonia, Dyspnoea, Hepatitis acute, Liver function test increased, Respiratory depression
Clinical narrative: Reported Symptoms: 10019717:HEPATITIS; 10024405:LFTS RAISED; 10038678:RESPIRATORY DEPRESSION; 10040047:SEPSIS; 10043088;TACHNYPNEA; 10084380:COVID-19 PNEUMONIA; Narrative: Patient received 5 Pfizer COVID 19 Vaccines (Jan, Feb, Oct, Nov 2021, Nov 2022) and 1 Moderna COVID 19 vaccine (April 2022). The patient presented to the ED on 19 July 2023 with shortness of breath. The patient tested positive for COVID 19 on 19 July 2023 and was admitted with COVID 19 pneumonia, sepsis, acute hepatitis, and respiratory failure. The patient was treated with antibiotics, steroids, and oxygen. The patient was discharged on 3 August 2023 in stable condition. Reported per EUA. Other Relevant HX: Other: covid pneumonia, sepsis, hepatitis
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Respiratory failure, SARS-CoV-2 test positive, Sepsis, Tachypnoea
Clinical narrative: Reported Symptoms: 10019717:HEPATITIS; 10024405:LFTS RAISED; 10038678:RESPIRATORY DEPRESSION; 10040047:SEPSIS; 10043088;TACHNYPNEA; 10084380:COVID-19 PNEUMONIA; Narrative: Patient received 5 Pfizer COVID 19 Vaccines (Jan, Feb, Oct, Nov 2021, Nov 2022) and 1 Moderna COVID 19 vaccine (April 2022). The patient presented to the ED on 19 July 2023 with shortness of breath. The patient tested positive for COVID 19 on 19 July 2023 and was admitted with COVID 19 pneumonia, sepsis, acute hepatitis, and respiratory failure. The patient was treated with antibiotics, steroids, and oxygen. The patient was discharged on 3 August 2023 in stable condition. Reported per EUA. Other Relevant HX: Other: covid pneumonia, sepsis, hepatitis
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Oedema peripheral
Clinical narrative: Reported Symptoms:  10042674:SWELLING; 10048750:AXILLARY PAIN;  Narrative: Other Relevant HX:  Other: Left armpit swelling and pain
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19 pneumonia, Cough, Dyspnoea, Respiratory depression, Respiratory failure
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10038678:RESPIRATORY DEPRESSION; 10043088:TACHYPNEA; 10084380:COVID-19 PNEUMONIA;  Narrative: Patient received three doses of Pfizer COVID 19 Vaccine (Jan/Feb/Sep 2021). The patient presented to the ED on 11 May 2023 with cough and shortness of breath. The patient tested positive for COVID 19 on 11 May 2023 and was admitted to the hospital with respiratory failure and COVID pneumonia. The patient was treated with dexamethasone, oxygen, and symptomatic relief. The patient was discharged on 15 May 2023 in stable condition. Reported per EUA. Other Relevant HX: Other: covid 19 pnuemonia
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Tachypnoea
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10038678:RESPIRATORY DEPRESSION; 10043088:TACHYPNEA; 10084380:COVID-19 PNEUMONIA;  Narrative: Patient received three doses of Pfizer COVID 19 Vaccine (Jan/Feb/Sep 2021). The patient presented to the ED on 11 May 2023 with cough and shortness of breath. The patient tested positive for COVID 19 on 11 May 2023 and was admitted to the hospital with respiratory failure and COVID pneumonia. The patient was treated with dexamethasone, oxygen, and symptomatic relief. The patient was discharged on 15 May 2023 in stable condition. Reported per EUA. Other Relevant HX: Other: covid 19 pnuemonia
Age: 61.0
Sex: F
Vaccine: PNC20
Symptoms: Chills, Tachycardia
Clinical narrative: Reported Symptoms: 10008531:CHILLS; 10043071:TACHYCARDIA; Narrative: Other Relevant HX: Other: chills
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Angina pectoris, COVID-19, Chills, Cough
Clinical narrative: Reported Symptoms: 10002391:ANGINAL PAIN; 10042772:SYNCOPE; 10058267:TROPONIN INCREASED; 10084268:COVID-19;  Narrative: Patient received one dose Janssen COVID 19 Vaccine April 2021. The patient presented to the ED on 1 May 2023 after losing consciousness with malaise, fever, dry cough, and chills. The patient tested positive for COVID 19 and was admitted with COVID 19, elevated troponin, NSTEMI, and syncope. The patient was treated with oxygen and has cardiology consult. The patient left against medical advice on 4 May 2023. Other Relevant HX: Other: elevated troponin, COVID 19
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Loss of consciousness, Malaise, Pyrexia, SARS-CoV-2 test positive, Syncope
Clinical narrative: Reported Symptoms: 10002391:ANGINAL PAIN; 10042772:SYNCOPE; 10058267:TROPONIN INCREASED; 10084268:COVID-19;  Narrative: Patient received one dose Janssen COVID 19 Vaccine April 2021. The patient presented to the ED on 1 May 2023 after losing consciousness with malaise, fever, dry cough, and chills. The patient tested positive for COVID 19 and was admitted with COVID 19, elevated troponin, NSTEMI, and syncope. The patient was treated with oxygen and has cardiology consult. The patient left against medical advice on 4 May 2023. Other Relevant HX: Other: elevated troponin, COVID 19
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin increased
Clinical narrative: Reported Symptoms: 10002391:ANGINAL PAIN; 10042772:SYNCOPE; 10058267:TROPONIN INCREASED; 10084268:COVID-19;  Narrative: Patient received one dose Janssen COVID 19 Vaccine April 2021. The patient presented to the ED on 1 May 2023 after losing consciousness with malaise, fever, dry cough, and chills. The patient tested positive for COVID 19 and was admitted with COVID 19, elevated troponin, NSTEMI, and syncope. The patient was treated with oxygen and has cardiology consult. The patient left against medical advice on 4 May 2023. Other Relevant HX: Other: elevated troponin, COVID 19
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Confusional state, Cough, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10010300:CONFUSION; 10011232:COUGHING; 10043088:TACHYPNEA; 10084380:COVID-19 PNEUMONIA; Narrative: Patient received 2 doses of Pfizer COVID 19 vaccine Jan/Feb 2021. The patient presented to the ED on 11 Jan 23 with cough and confusion. The patient tested positive for COVID 19 on 11 Jan 23 and was admitted with COVID pneumonia. The patient was treated with antibiotics, remdesivir, and dexamethasone. The patient was discharged on 18 Jan 23 in stable condition. Reported per EUA. Other Relevant HX: Other: covid pneumonia
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tachypnoea
Clinical narrative: Reported Symptoms: 10010300:CONFUSION; 10011232:COUGHING; 10043088:TACHYPNEA; 10084380:COVID-19 PNEUMONIA; Narrative: Patient received 2 doses of Pfizer COVID 19 vaccine Jan/Feb 2021. The patient presented to the ED on 11 Jan 23 with cough and confusion. The patient tested positive for COVID 19 on 11 Jan 23 and was admitted with COVID pneumonia. The patient was treated with antibiotics, remdesivir, and dexamethasone. The patient was discharged on 18 Jan 23 in stable condition. Reported per EUA. Other Relevant HX: Other: covid pneumonia
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Acute left ventricular failure, Atrial fibrillation, Blood potassium increased, COVID-19, Cardiac ablation
Clinical narrative: Reported Symptoms: 10040604:SHORTNESS OF BREATH; 10052521:NASAL SINUS DRAINAGE; Narrative: 5/10/23 - Pt called the Clinical Contact Center at facility to report c/o SOB on normal activities which started 4 days ago. He reported he wakes up at night with SOB. It was recommended Pt go to the ED for evaluation. 5/10/23 at 10:56 - Pt arrived at ED c/o SOB, nasal congestion and drainage but is not really coughing much. SOB worse with exertion. Pt has hx of COPD and is on home oxygen. He states at rest he is fine. Pt also with increased lower extremity edema which occurred 3 weeks prior. In ED: Patient placed on the monitor and was found to be in accelerated junctional rhythm. Sats were 99% at the time of exam and Pt was in no respiratory distress. Pt's potassium came back elevated at 6.5. IV calcium, bicarb, insulin, dextrose, and oral potassium initiated. Pt admitted to not taking his lasix as prescribed, but does take scheduled spironolactone and potassium supplement. CXR negative for acute pulmonary findings. Pt was admitted to hospital for primary diagnosis = hyperkalemia, acute on chronic diastolic heart failure, COPD exacerbation, dyspnea, CKD, and hyperglycemia. CURRENT MEDICAL PROBLEMS: Paroxysmal afib s/p ablasion in 2022 per patient Acute GIB while on anticoagulation Chronic hypoxic respiratory failure requiring continous O2 Stage 3B CKD Pulmonary HTN Noncompliant OSA Moderate COPD HTN HLD Gout Obesity Vitamin D deficiency PMH: History of bilateral renal calculi Multiple renal cystic lesions, some complex Pt remained at hospital from 5/10/23 to 5/22/23.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac monitoring abnormal, Chest X-ray normal, Chronic kidney disease, Chronic left ventricular failure, Chronic obstructive pulmonary disease
Clinical narrative: Reported Symptoms: 10040604:SHORTNESS OF BREATH; 10052521:NASAL SINUS DRAINAGE; Narrative: 5/10/23 - Pt called the Clinical Contact Center at facility to report c/o SOB on normal activities which started 4 days ago. He reported he wakes up at night with SOB. It was recommended Pt go to the ED for evaluation. 5/10/23 at 10:56 - Pt arrived at ED c/o SOB, nasal congestion and drainage but is not really coughing much. SOB worse with exertion. Pt has hx of COPD and is on home oxygen. He states at rest he is fine. Pt also with increased lower extremity edema which occurred 3 weeks prior. In ED: Patient placed on the monitor and was found to be in accelerated junctional rhythm. Sats were 99% at the time of exam and Pt was in no respiratory distress. Pt's potassium came back elevated at 6.5. IV calcium, bicarb, insulin, dextrose, and oral potassium initiated. Pt admitted to not taking his lasix as prescribed, but does take scheduled spironolactone and potassium supplement. CXR negative for acute pulmonary findings. Pt was admitted to hospital for primary diagnosis = hyperkalemia, acute on chronic diastolic heart failure, COPD exacerbation, dyspnea, CKD, and hyperglycemia. CURRENT MEDICAL PROBLEMS: Paroxysmal afib s/p ablasion in 2022 per patient Acute GIB while on anticoagulation Chronic hypoxic respiratory failure requiring continous O2 Stage 3B CKD Pulmonary HTN Noncompliant OSA Moderate COPD HTN HLD Gout Obesity Vitamin D deficiency PMH: History of bilateral renal calculi Multiple renal cystic lesions, some complex Pt remained at hospital from 5/10/23 to 5/22/23.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Dyspnoea, Dyspnoea exertional, Hyperglycaemia, Hyperkalaemia
Clinical narrative: Reported Symptoms: 10040604:SHORTNESS OF BREATH; 10052521:NASAL SINUS DRAINAGE; Narrative: 5/10/23 - Pt called the Clinical Contact Center at facility to report c/o SOB on normal activities which started 4 days ago. He reported he wakes up at night with SOB. It was recommended Pt go to the ED for evaluation. 5/10/23 at 10:56 - Pt arrived at ED c/o SOB, nasal congestion and drainage but is not really coughing much. SOB worse with exertion. Pt has hx of COPD and is on home oxygen. He states at rest he is fine. Pt also with increased lower extremity edema which occurred 3 weeks prior. In ED: Patient placed on the monitor and was found to be in accelerated junctional rhythm. Sats were 99% at the time of exam and Pt was in no respiratory distress. Pt's potassium came back elevated at 6.5. IV calcium, bicarb, insulin, dextrose, and oral potassium initiated. Pt admitted to not taking his lasix as prescribed, but does take scheduled spironolactone and potassium supplement. CXR negative for acute pulmonary findings. Pt was admitted to hospital for primary diagnosis = hyperkalemia, acute on chronic diastolic heart failure, COPD exacerbation, dyspnea, CKD, and hyperglycemia. CURRENT MEDICAL PROBLEMS: Paroxysmal afib s/p ablasion in 2022 per patient Acute GIB while on anticoagulation Chronic hypoxic respiratory failure requiring continous O2 Stage 3B CKD Pulmonary HTN Noncompliant OSA Moderate COPD HTN HLD Gout Obesity Vitamin D deficiency PMH: History of bilateral renal calculi Multiple renal cystic lesions, some complex Pt remained at hospital from 5/10/23 to 5/22/23.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Nasal congestion, Nodal rhythm, Oedema peripheral, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10040604:SHORTNESS OF BREATH; 10052521:NASAL SINUS DRAINAGE; Narrative: 5/10/23 - Pt called the Clinical Contact Center at facility to report c/o SOB on normal activities which started 4 days ago. He reported he wakes up at night with SOB. It was recommended Pt go to the ED for evaluation. 5/10/23 at 10:56 - Pt arrived at ED c/o SOB, nasal congestion and drainage but is not really coughing much. SOB worse with exertion. Pt has hx of COPD and is on home oxygen. He states at rest he is fine. Pt also with increased lower extremity edema which occurred 3 weeks prior. In ED: Patient placed on the monitor and was found to be in accelerated junctional rhythm. Sats were 99% at the time of exam and Pt was in no respiratory distress. Pt's potassium came back elevated at 6.5. IV calcium, bicarb, insulin, dextrose, and oral potassium initiated. Pt admitted to not taking his lasix as prescribed, but does take scheduled spironolactone and potassium supplement. CXR negative for acute pulmonary findings. Pt was admitted to hospital for primary diagnosis = hyperkalemia, acute on chronic diastolic heart failure, COPD exacerbation, dyspnea, CKD, and hyperglycemia. CURRENT MEDICAL PROBLEMS: Paroxysmal afib s/p ablasion in 2022 per patient Acute GIB while on anticoagulation Chronic hypoxic respiratory failure requiring continous O2 Stage 3B CKD Pulmonary HTN Noncompliant OSA Moderate COPD HTN HLD Gout Obesity Vitamin D deficiency PMH: History of bilateral renal calculi Multiple renal cystic lesions, some complex Pt remained at hospital from 5/10/23 to 5/22/23.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Sinus operation, Sleep disorder
Clinical narrative: Reported Symptoms: 10040604:SHORTNESS OF BREATH; 10052521:NASAL SINUS DRAINAGE; Narrative: 5/10/23 - Pt called the Clinical Contact Center at facility to report c/o SOB on normal activities which started 4 days ago. He reported he wakes up at night with SOB. It was recommended Pt go to the ED for evaluation. 5/10/23 at 10:56 - Pt arrived at ED c/o SOB, nasal congestion and drainage but is not really coughing much. SOB worse with exertion. Pt has hx of COPD and is on home oxygen. He states at rest he is fine. Pt also with increased lower extremity edema which occurred 3 weeks prior. In ED: Patient placed on the monitor and was found to be in accelerated junctional rhythm. Sats were 99% at the time of exam and Pt was in no respiratory distress. Pt's potassium came back elevated at 6.5. IV calcium, bicarb, insulin, dextrose, and oral potassium initiated. Pt admitted to not taking his lasix as prescribed, but does take scheduled spironolactone and potassium supplement. CXR negative for acute pulmonary findings. Pt was admitted to hospital for primary diagnosis = hyperkalemia, acute on chronic diastolic heart failure, COPD exacerbation, dyspnea, CKD, and hyperglycemia. CURRENT MEDICAL PROBLEMS: Paroxysmal afib s/p ablasion in 2022 per patient Acute GIB while on anticoagulation Chronic hypoxic respiratory failure requiring continous O2 Stage 3B CKD Pulmonary HTN Noncompliant OSA Moderate COPD HTN HLD Gout Obesity Vitamin D deficiency PMH: History of bilateral renal calculi Multiple renal cystic lesions, some complex Pt remained at hospital from 5/10/23 to 5/22/23.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Confusional state, Cough, Dyspnoea, Malaise
Clinical narrative: Reported Symptoms: 10010300:CONFUSION; 10011232:COUGHING; 10028411:MYALGIA; 10040047:SEPSIS; 10084380:COVID-19 PNEUMONIA; Narrative: Patient received one dose Moderna COVID 19 Vaccine Oct 2022. The patient presented to the ED on 18 Jan 23 with fever, cough, malaise, shortness of breath, and confusion. The patient tested positive for COVID 19 on 18 Jan 23 and was admitted to the hospital with COVID 19 pneumonia and sepsis. The patient was treated with remdesivir and antibiotics. The patient was discharged in stable condition on 23 Jan 23. Reported per EUA. Other Relevant HX: Other: covid pneumonia and sepsis
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Reported Symptoms: 10010300:CONFUSION; 10011232:COUGHING; 10028411:MYALGIA; 10040047:SEPSIS; 10084380:COVID-19 PNEUMONIA; Narrative: Patient received one dose Moderna COVID 19 Vaccine Oct 2022. The patient presented to the ED on 18 Jan 23 with fever, cough, malaise, shortness of breath, and confusion. The patient tested positive for COVID 19 on 18 Jan 23 and was admitted to the hospital with COVID 19 pneumonia and sepsis. The patient was treated with remdesivir and antibiotics. The patient was discharged in stable condition on 23 Jan 23. Reported per EUA. Other Relevant HX: Other: covid pneumonia and sepsis
Sex: M
Vaccine: COVID19-2, FLUX
Symptoms: Areflexia, Ataxia, Faecaloma, Gait disturbance, Guillain-Barre syndrome
Clinical narrative: Reported Symptoms: 10018767:  GUILLAIN-BARRE SYNDROME; Narrative: 52 y/o R-handed male patient essentially previously healthy who presented with subacute painless weakness and sensory deficit of BLE and distal BUE associated with gait change and stool retention. Symptom began 4-6 weeks after receiving influenza and second COVID-19 booster vaccination. Examination notable for weakness and sensory ataxia with areflexia; clinical and electrodiagnostically congruent with AIDP. Patient required IVIG treatments. Other Relevant HX: Other: GUILLIAN BARRE